These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35339342)

  • 21. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel insights into the pathomechanisms of skeletal muscle channelopathies.
    Burge JA; Hanna MG
    Curr Neurol Neurosci Rep; 2012 Feb; 12(1):62-9. PubMed ID: 22083238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plateau potentials contribute to myotonia in mouse models of myotonia congenita.
    Wang X; Dupont C; Grant D; Voss AA; Rich MM
    Exp Neurol; 2023 Mar; 361():114303. PubMed ID: 36563835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal Muscle Channelopathies.
    Vivekanandam V; Munot P; Hanna MG; Matthews E
    Neurol Clin; 2020 Aug; 38(3):481-491. PubMed ID: 32703462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of physiological ClC-1 Cl- ion channel regulation for the excitability and function of working skeletal muscle.
    Pedersen TH; Riisager A; de Paoli FV; Chen TY; Nielsen OB
    J Gen Physiol; 2016 Apr; 147(4):291-308. PubMed ID: 27022190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle channelopathies: recent advances in genetics, pathophysiology and therapy.
    Suetterlin K; Männikkö R; Hanna MG
    Curr Opin Neurol; 2014 Oct; 27(5):583-90. PubMed ID: 25188014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostics in skeletal muscle channelopathies.
    Vicino A; Brugnoni R; Maggi L
    Expert Rev Mol Diagn; 2023; 23(12):1175-1193. PubMed ID: 38009256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal muscle ClC-1 chloride channels in health and diseases.
    Altamura C; Desaphy JF; Conte D; De Luca A; Imbrici P
    Pflugers Arch; 2020 Jul; 472(7):961-975. PubMed ID: 32361781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium Channelopathies of Skeletal Muscle.
    Cannon SC
    Handb Exp Pharmacol; 2018; 246():309-330. PubMed ID: 28939973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium channelopathies of skeletal muscle result from gain or loss of function.
    Jurkat-Rott K; Holzherr B; Fauler M; Lehmann-Horn F
    Pflugers Arch; 2010 Jul; 460(2):239-48. PubMed ID: 20237798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.
    Statland JM; Barohn RJ
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1598-614. PubMed ID: 24305449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Channelopathies of skeletal muscle excitability.
    Cannon SC
    Compr Physiol; 2015 Apr; 5(2):761-90. PubMed ID: 25880512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle.
    Lueck JD; Rossi AE; Thornton CA; Campbell KP; Dirksen RT
    J Gen Physiol; 2010 Dec; 136(6):597-613. PubMed ID: 21078869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum electrolyte concentrations and skeletal muscle excitability in vivo.
    Boland-Freitas R; Lee JH; Ng K
    Clin Neurophysiol; 2022 Mar; 135():13-21. PubMed ID: 35007839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcolemmal excitability changes in normal human aging.
    Lee JHF; Boland-Freitas R; Ng K
    Muscle Nerve; 2018 Jun; 57(6):981-988. PubMed ID: 29314071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies.
    Meola G; Sansone V; Rotondo G; Mancinelli E
    Eur J Histochem; 2003; 47(1):17-28. PubMed ID: 12685554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy.
    Wheeler TM; Lueck JD; Swanson MS; Dirksen RT; Thornton CA
    J Clin Invest; 2007 Dec; 117(12):3952-7. PubMed ID: 18008009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy.
    Allen DC; Arunachalam R; Mills KR
    Muscle Nerve; 2008 Jan; 37(1):14-22. PubMed ID: 17763454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of transverse-tubular chloride conductance on excitability in skinned skeletal muscle fibres of rat and toad.
    Coonan JR; Lamb GD
    J Physiol; 1998 Jun; 509 ( Pt 2)(Pt 2):551-64. PubMed ID: 9575303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.